Analysis of Iliac Crest Biopsies From Patients Receiving Risedronate

Warner Chilcott

Status: Completed

Conditions: Osteoporosis

Treatments: Drug: risedronate

Study type: Observational

Funder types: Industry

Identifiers

NCT00837746

2004140

Details and patient eligibility

About

This study analysed and reported on the study data from three similar, risedronate studies, 1996052, 2003073, and 2003096. The objective of the study was to determine the differences in the iliac crest bone histomorphometry and bone quality in postmenopausal women who had received long term therapy with risedronate.

Enrollment: 29 patients

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion criteria

• Completed month 36 of Study RVN-008993.
• Underwent an iliac crest bone biopsy at month 36.

Exclusion criteria

• Was less than 60% compliant with regard to taking study drug from the start of the study drug to month 24 of study RVN-008993.

Trial design

29 participants in 1 patient group

1

Description:

Women taking risedronate for 5 years

Treatment:

Drug: risedronate